Concepedia
Statistics
Publications
27
Citations
1K
H-Index
19
Active since
2004
Affiliations
Loughborough University(Current)
AstraZeneca (Sweden)
AstraZeneca (United Kingdom)
AstraZeneca (United States)
AstraZeneca (Australia)
Ken Grime is an author at Loughborough University specializing in pharmacology, pharmacokinetics, and pharmacy.
Publications per year
2004–2025
Use of Hepatocytes to Assess the Contribution of Hepatic Uptake to Clearance in Vivo
Matthew G. Soars, Ken Grime, Joanne L. Sproston et al. · Drug Metabolism and Disposition · 2007 · 142 citations
Pharmacy, Pharmacokinetics, Pharmacology +17
EVALUATION OF TIME-DEPENDENT CYTOCHROME P450 INHIBITION USING CULTURED HUMAN HEPATOCYTES
Dermot F. McGinnity, Amanda J. Berry, Jane R. Kenny et al. · Drug Metabolism and Disposition · 2006 · 99 citations
Medicine, Pharmacokinetics, Pharmacology +17
AUTOMATED ASSESSMENT OF TIME-DEPENDENT INHIBITION OF HUMAN CYTOCHROME P450 ENZYMES USING LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY ANALYSIS
Anthony C. Atkinson, Jane R. Kenny, Ken Grime · Drug Metabolism and Disposition · 2005 · 96 citations
Metabolic screening in vitro: metabolic stability, CYP inhibition and induction
Robert J. Riley, Ken Grime · Drug Discovery Today Technologies · 2004 · 56 citations
Medicine, Biochemistry, Pharmacology +16
Species Differences in Biliary Clearance and Possible Relevance of Hepatic Uptake and Efflux Transporters Involvement
Ken Grime, Stuart W. Paine · Drug Metabolism and Disposition · 2012 · 55 citations
1–5 of 27